DexCom, Inc. (DXCM) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
DXCM Revenue Growth
Revenue Breakdown
DXCM's revenue distribution by segment and geography
By Geography
DXCM Revenue Analysis (2014–2025)
As of May 6, 2026, DexCom, Inc. (DXCM) generated trailing twelve-month (TTM) revenue of $4.82 billion, reflecting strong growth of +15.0% year-over-year. The most recent quarter (Q1 2026) recorded $1.19 billion in revenue, down 5.4% sequentially.
Looking at the longer-term picture, DXCM's 5-year compound annual growth rate (CAGR) stands at +19.3%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $4.66 billion in 2025, representing a new all-time high.
When compared to Healthcare sector peers including ABT (+6.4% YoY), PODD (+27.1% YoY), and TNDM (-4.2% YoY), DXCM has underperformed the peer group in terms of revenue growth. Compare DXCM vs ABT →
DXCM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| DXCMCurrent | $4.8B | +15.0% | +19.3% | 19.6% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% | |
 PODD | $2.7B | +27.1% | +24.5% | 17.5% | |
 TNDM | $1.0B | -4.2% | +15.3% | -7.7% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 INVA | $425M | +14.5% | +4.8% | 38.5% |
DXCM Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $4.66B | +15.6% | $2.80B | 60.0% | $911.8M | 19.6% |
| 2024 | $4.03B | +11.3% | $2.44B | 60.5% | $600.0M | 14.9% |
| 2023 | $3.62B | +24.5% | $2.29B | 63.2% | $597.7M | 16.5% |
| 2022 | $2.91B | +18.8% | $1.88B | 64.7% | $391.2M | 13.4% |
| 2021 | $2.45B | +27.1% | $1.68B | 68.6% | $265.8M | 10.9% |
| 2020 | $1.93B | +30.5% | $1.28B | 66.4% | $299.5M | 15.5% |
| 2019 | $1.48B | +43.1% | $931.5M | 63.1% | $142.3M | 9.6% |
| 2018 | $1.03B | +43.6% | $663.9M | 64.4% | $-186,300,000 | -18.1% |
| 2017 | $718.5M | +25.3% | $492.1M | 68.5% | $-42,500,000 | -5.9% |
| 2016 | $573.3M | +42.6% | $378.4M | 66.0% | $-63,900,000 | -11.1% |
Full DXCM Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See DXCM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DXCM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DXCM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDXCM — Frequently Asked Questions
Quick answers to the most common questions about buying DXCM stock.
Is DXCM's revenue growth accelerating or slowing?
DXCM maintains +15.0% revenue growth, in line with its 5-year CAGR of +19.3%. TTM revenue stands at $4.8B. Growth rate remains consistent with historical average.
What is DXCM's long-term revenue growth rate?
DexCom, Inc.'s 5-year revenue CAGR of +19.3% reflects the sustained expansion pattern. Current YoY growth of +15.0% is near this long-term average.
How is DXCM's revenue distributed by segment?
DXCM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.